14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $36.77 $55.69 Wednesday, 1st May 2024 BHVN stock ended at $40.18. This is 3.56% more than the trading day before Tuesday, 30th Apr 2024. During the day the stock fluctuated 8.34% from a day low at $38.43 to a day high of $41.64.
90 days $36.77 $62.21
52 weeks $13.03 $62.21

Historical Biohaven Pharmaceutical Holding Company Ltd prices

Date Open High Low Close Volume
Aug 21, 2023 $19.33 $19.65 $19.08 $19.46 421 464
Aug 18, 2023 $18.98 $19.59 $18.53 $19.27 518 684
Aug 17, 2023 $20.24 $20.44 $19.11 $19.22 578 295
Aug 16, 2023 $20.65 $20.71 $19.52 $19.88 573 251
Aug 15, 2023 $20.54 $21.04 $20.25 $20.75 410 148
Aug 14, 2023 $20.64 $20.71 $20.19 $20.52 581 274
Aug 11, 2023 $21.19 $21.81 $20.81 $20.84 304 769
Aug 10, 2023 $21.00 $21.65 $20.95 $21.20 330 599
Aug 09, 2023 $20.20 $21.27 $20.12 $21.25 579 677
Aug 08, 2023 $19.43 $20.65 $19.25 $20.28 664 993
Aug 07, 2023 $20.75 $20.94 $19.00 $19.23 898 265
Aug 04, 2023 $19.22 $19.96 $18.98 $19.69 714 354
Aug 03, 2023 $19.15 $19.74 $18.90 $19.15 670 262
Aug 02, 2023 $19.43 $20.11 $18.80 $19.28 862 657
Aug 01, 2023 $19.71 $20.17 $19.13 $19.65 1 255 147
Jul 31, 2023 $19.27 $20.43 $19.03 $19.88 1 399 701
Jul 28, 2023 $18.50 $19.08 $18.17 $19.05 1 436 622
Jul 27, 2023 $19.67 $20.10 $17.10 $18.42 5 536 571
Jul 26, 2023 $23.74 $24.05 $23.29 $23.80 1 114 967
Jul 25, 2023 $23.90 $24.38 $23.31 $23.70 1 356 219
Jul 24, 2023 $25.39 $25.59 $23.13 $23.83 1 674 804
Jul 21, 2023 $24.98 $25.75 $24.90 $25.44 891 969
Jul 20, 2023 $25.77 $25.68 $24.58 $24.75 650 685
Jul 19, 2023 $26.24 $26.31 $25.32 $25.53 567 851
Jul 18, 2023 $26.20 $26.59 $25.95 $26.24 450 351
Click to get the best stock tips daily for free!

About Biohaven Pharmaceutical Holding Company Ltd

Biohaven Pharmaceutical Holding Company Ltd Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavegepant that is in phase III clinical trials for acute and preventive treatment of migraine, as well as re... BHVN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT